Delivery Order SPE2DB22D3301-SPE2DB24FY6LR

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $26K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The $1,451.40 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 24, 2023 and is a firm fixed price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5ml to the Defense Logistics Agency (DLA). The $2,031.96 award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (3 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The $26,127.03 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 15, 2024 and was awarded on February 14, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (1.5 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA). The $7,940.12 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 6, 2024. The contract has a period of performance through November 7, 2024 and was not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (3 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The $14,806.24 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through February 12, 2024 and was not designated as a set-aside award. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen 0.5ml to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,761.29 and an ultimate completion date of December 6, 2023. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
The federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,549.92 delivery order contract is with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 8, 2022. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive...
This contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The $4,682.03 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of July 30, 2024 and was not set aside for any specific business type. Amerisourcebergen has significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $3,972.90 and an ultimate completion date of January 25, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $2,467.38, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order with a firm fixed price and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY6LR
    Delivery Order

This federal contract award is for the supply of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract, valued at $26,455.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 10, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued at up to $750,000. These IDCs enable the company to efficiently supply a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.

Generated 5/16/25, 12:34 PM